BMI1 (B lymphoma Mo-MLV insertion region 1), also known as polycomb group factor 4 (PCGF4), has emerged as a pivotal epigenetic regulator implicated in the maintenance of aggressive cancer phenotypes, including ARMS. Here, BMI1 is linked to cancer.